|
NCOA7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.867600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.153000E-01 |
| Normal-vs-Stage2 |
1.259030E-01 |
| Normal-vs-Stage3 |
3.648600E-01 |
| Normal-vs-Stage4 |
1.265820E-01 |
| Stage1-vs-Stage2 |
1.456380E-01 |
| Stage1-vs-Stage3 |
3.782600E-01 |
| Stage1-vs-Stage4 |
5.948200E-02 |
| Stage2-vs-Stage3 |
2.872600E-01 |
| Stage2-vs-Stage4 |
7.439600E-01 |
| Stage3-vs-Stage4 |
3.421600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.984800E-01 |
| Normal-vs-AfricanAmerican |
7.759200E-01 |
| Normal-vs-Asian |
7.218000E-01 |
| Caucasian-vs-AfricanAmerican |
8.932800E-01 |
| Caucasian-vs-Asian |
8.202800E-01 |
| AfricanAmerican-vs-Asian |
9.725200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.511190E-01 |
| Normal-vs-Female |
5.927800E-01 |
| Male-vs-Female |
9.119700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.266200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.986430E-01 |
| Normal-vs-Age(61-80Yrs) |
4.284200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.275600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.023600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.060670E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.397000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.385600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.744000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.995400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.841600E-01 |
| Classical-VS-Follicular |
1.96149985143279E-10 |
| Classical-VS-Other |
7.453800E-01 |
| Classical-VS-Normal |
9.840600E-01 |
| Tall-VS-Follicular |
3.06380000003603E-06 |
| Tall-VS-Other |
6.496200E-01 |
| Tall-VS-Normal |
9.089000E-01 |
| Follicular-VS-Other |
4.040200E-02 |
| Follicular-VS-Normal |
1.577400E-03 |
| Other-VS-Normal |
7.429600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.712300E-02 |
| Normal-vs-N1 |
6.598000E-01 |
| N0-vs-N1 |
4.694200E-02 |
|
|
